Istituzioni

The FDA is providing an update on additional steps it has taken that will lead to more infant formula on U.S. store shelves in the coming weeks and months.

The FDA is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with certain allergies or critical health conditions.

FDA is providing an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA approved the first treatment for eosinophilic esophagitis, a chronic immune disorder, in adults and pediatric patients (12 years and older weighing at least 40 kilograms, which is about 88 pounds).

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA is issuing a draft guidance, Risk Management Plans to Mitigate the Potential for Drug Shortages, intended to help with the development, maintenance and implementation of risk management plans.

The FDA announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient (NDI) notifications.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine

FDA announced guidance outlining increased flexibilities on importation of certain infant formula products to further increase the availability across the country while protecting the health of infants.

Under the proposed consent decree, Abbott has agreed to take corrective actions following an FDA inspection of its Sturgis, Michigan, facility.

Today, FDA authorized the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test, the first direct-to-consumer (non-prescription) multi-analyte COVID-19 test authorized by FDA.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA approved a new treatment to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA is providing an update on its work to increase the availability of infant and specialty formula products.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 older for whom other available COVID-19 vaccines are not accessible or clinically appropriate, and to individuals 18 and older who elect to receive it because they would otherwise not receive a COVID-19 vaccine.

FDA today permitted marketing for the first in vitro diagnostic test for early detection of amyloid plaques associated with Alzheimer’s disease.